$HSTM

HEALTHSTREAM INC (HSTM): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

HEALTHSTREAM INC (HSTM) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On September 18, 2026, the Compensation Committee (the “Committee”) of the Board of Directors of HealthStream, Inc. (the “Co

Original reporting
Published Sep 23, 2026, 8:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 23, 2026, 8:26 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$HSTM
Neutral
high confidence
Mentioned
$HSTM
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$HSTMNeutralLow
01

Why it matters

The filing is a routine corporate action with limited trading relevance.

02

Market read

Low relevance; the filing provides new but minor information about executive RSU awards.

03

What to watch

Potential dilution if many RSUs vest in future years, though impact remains minimal.

Relevance 6/10Novelty 3/10Timing: filed Sep 23 2026

Background

HealthStream Inc. filed an 8‑K reporting executive compensation under its 2022 Omnibus Incentive Plan.

Company-level read

Ticker impact

$HSTMNeutralHigh confidence
Context

SEC Form 8‑K disclosed new time‑based and performance‑based RSU grants to four executives and the CFO.

Expected impact

No significant price change expected in the short term.

Evidence & confidence

The disclosed amounts are small relative to market cap and the filing is routine compensation reporting.

Market effects

None; compensation filing does not affect the broader health‑tech sector.

None; the news is company‑specific.

None

Counterpoint

Even small RSU grants could signal confidence in future performance, but market likely ignores it.

Key entities

  • HealthStream Inc.

    US‑listed health‑tech firm (NASDAQ: HSTM).

Related articles

$HSTMMed

WJRJJ Ventures Discloses Investment at HealthStream with 9.6% Stake

WJRJJ Ventures disclosed a 9.6% stake in HealthStream, acquired through open-market buys and a deal at $29.50 per share. The investment includes a one-year standstill and registration rights. WJRJJ plans to hold shares for investment but may buy or sell more over time. Willis Johnson, managing member of WJRJJ, is involved in the investment.

$HSTMHigh

HEALTHSTREAM ANNOUNCES SECOND QUARTER 2026 RESULTS

HEALTHSTREAM INC (HSTM) filed an SEC Form 8-K — Results of Operations and Financial Condition. HealthStream Announces Second Quarter 2026 Results Page 1 August 3, 2026 Exhibit 99.1 Contact: Scott A. Roberts Chief Financial Officer (615) 301-3182 ir@healthstream.com Media: Mollie Condra, Ph.D. Head, Investor Relations & Communications (615) 301-3237 mollie.condra@healthstre